RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
AIM ImmunoTech Stock

AIM ImmunoTech Debt 2024

AIM ImmunoTech Debt

-5.44 USD

Ticker

AIM

ISIN

US00901B1052

WKN

A2PREX

In 2024, AIM ImmunoTech's total debt was -5.44 USD, a -79.9% change from the -27.05 USD total debt recorded in the previous year.

AIM ImmunoTech Aktienanalyse

What does AIM ImmunoTech do?

AIM ImmunoTech Inc is a US-based biotechnology company that focuses on the development of immunotherapeutics and diagnostics for humans and animals. The company has been in operation for over 30 years and specializes in the treatment of viral and autoimmune diseases. AIM ImmunoTech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding AIM ImmunoTech's Debt Structure

AIM ImmunoTech's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing AIM ImmunoTech's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to AIM ImmunoTech’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in AIM ImmunoTech’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about AIM ImmunoTech stock

What is the debt of AIM ImmunoTech this year?

AIM ImmunoTech has a debt level of -5.44 USD this year.

What was the debt of AIM ImmunoTech compared to the previous year?

The debt of AIM ImmunoTech has increased by -79.9% compared to the previous year dropped.

What are the consequences of high debt for investors in AIM ImmunoTech?

High debt can pose a risk for investors of AIM ImmunoTech, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of AIM ImmunoTech?

Low debt means that AIM ImmunoTech has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from AIM ImmunoTech affect the company?

An increase in debt of AIM ImmunoTech can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of AIM ImmunoTech affect the company?

A reduction in debt of AIM ImmunoTech can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of AIM ImmunoTech?

Some factors that can influence the debt of AIM ImmunoTech include investments, acquisitions, operating costs, and revenue development.

Why are the debts of AIM ImmunoTech so important for investors?

The debts of AIM ImmunoTech are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can AIM ImmunoTech take to change the debt?

To change the debt, AIM ImmunoTech can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does AIM ImmunoTech pay?

Over the past 12 months, AIM ImmunoTech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, AIM ImmunoTech is expected to pay a dividend of 0 USD.

What is the dividend yield of AIM ImmunoTech?

The current dividend yield of AIM ImmunoTech is .

When does AIM ImmunoTech pay dividends?

AIM ImmunoTech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of AIM ImmunoTech?

AIM ImmunoTech paid dividends every year for the past 0 years.

What is the dividend of AIM ImmunoTech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is AIM ImmunoTech located?

AIM ImmunoTech is assigned to the 'Health' sector.

Wann musste ich die Aktien von AIM ImmunoTech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of AIM ImmunoTech from 9/13/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did AIM ImmunoTech pay the last dividend?

The last dividend was paid out on 9/13/2024.

What was the dividend of AIM ImmunoTech in the year 2023?

In the year 2023, AIM ImmunoTech distributed 0 USD as dividends.

In which currency does AIM ImmunoTech pay out the dividend?

The dividends of AIM ImmunoTech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von AIM ImmunoTech

Our stock analysis for AIM ImmunoTech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of AIM ImmunoTech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.